420 with CNW — New Study Finds That Cannabis Legalization Decreases Racially Biased Arrests

New research has found that states which maintain cannabis prohibition continue seeing increases in disparities in rates of arrest while those that decriminalize or legalize cannabis experience significant reductions in race-based arrests. The research was published by the American Medical Association in its JAMA journal. The report examined data collected from 43 states in the country in order to establish a clear pattern.

The researchers from Saint Louis University and Eastern Virginia Medical School analyzed arrests between 2008 and 2019, with a focus on trends associated with race. They discovered that over that period of time, states which legalized marijuana saw a 190-person drop in arrests for Caucasian people and a 560-person decline in arrests per 100,000 African Americans.

With regard to decriminalization, the researchers found a 117-person decline in arrests for Caucasian individuals and about 450-person drop in arrests per 100,000 African Americans. The researchers also found that racial disparities in arrests dropped in states which enacted reform and rose in those that maintain prohibition, noting that rates of arrest increased for Black individuals and remained stable for their White counterparts. In addition, they found that data on cannabis arrests in adolescents shows that younger individuals faced a lower risk of being arrested under decriminalization in comparison with legalization.

In their report, the researchers explained that arrest trends showed almost no change in the rates of arrest of Black and White young people in states that had implemented marijuana legalization, which isn’t surprising, if one considers that young people aren’t included in the legalized market, as it targets people aged 21 and above. They note that despite this result, it is important to continue to monitor the effects of policy changes as well as advocate for targeted policies that address arrest disparities and youth arrests.

This research confirms that while arrests for White individuals remained almost the same, the arrest rate disparity increased over time for Black individuals in states that didn’t implement policy changes, which is what advocates of reform have argued for. In their conclusion, the researchers note that the study’s results called attention to the need for targeted interventions that address racial injustice.

This isn’t the first time marijuana policy and the racist effect of the drug war on Black people in the United States has been discussed or mentioned in studies. Nora Volkow, head of the National Institute on Drug Abuse, has on more than one occasion criticized and called attention to the racial disparities in the enforcement of drug criminalization.

When one sees these arrest disparities in jurisdictions with prohibitionist laws, a new appreciation of the deeper role legal cannabis companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS) indirectly play by promoting equity comes to light.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — The EU Legalizes CBD as Cosmetics Ingredient

Despite the CBD industry’s runaway success in the past couple of years, the sector’s position in several territories is tenuous at best. A relatively new product, cannabidiol (“CBD”) has attracted a ton of consumer attention thanks to claims of its medical efficacy. However, experts say that the hype has outpaced science because there is limited research into the possible benefits and risks of CBD. Furthermore, the European Cosmetic Regulation 1224/2009 prohibits the use of cannabis and its extracts in cosmetics. European authorities have been quite strict against firms in the CBD space as a result, passing policies such as the ban on using cannabis extracts such as cannabidiol in cosmetics.

Fortunately for players interested in entering the CBD cosmetics segment, the EU has legalized the use of cannabidiol as an ingredient in cosmetics. This February, the EU’s directorate-general for internal market, industry, entrepreneurship and SMEs added CBD to the list of legal cosmetic ingredients its Cosing guidelines. This is a cosmetic regulations database that lists authorized and outlawed cosmetic ingredients as well as their uses and functions. With this addition, CBD companies that choose to develop CBD-infused cosmetics can do so without fear of persecution from the authorities.

The CBD cosmetics segment has been on the rise for the past couple of years. Studies have found that CBD has anti-inflammatory and antioxidant properties that make it effective at treating skin conditions, including breakouts, acne, eczema and psoriasis. The global CBD cosmetics market was estimated to be worth $633.6 million in 2018, and it is projected to hit a whopping $1.7 billion by 2025 due to increased awareness of the healing power of CBD cosmetics. Demand for CBD, in general, has been on the rise in Europe, and the European CBD market is projected to grow by 400% over the next couple of years.

CBD’s addition to the EU’s list of legal cosmetic ingredients came after the European Industrial Hemp Association, a transnational organization that promotes the objectives of European industrial hemp entrepreneurs, submitted a proposal to the EU asking it to add CBD to the Cosing database. The organization also asked for the inclusion of a trio of new International Nomenclature Cosmetic Ingredient (“INCI”) names — root extracts from Cannabis Sativa, leaf/stem extracts from cannabis sativa and leaf extracts from Cannabis Sativa — as well as the removal of Cannabis Sativa L restrictions.

The infamous Kanavape Case was also partly responsible for CBD’s entry into the Cosing guidelines. Two French businessmen found themselves facing charges when they imported and marketed CBD oil extracted from hemp biomass with the aim of using it in e-cigarettes. Although their actions were in line with EU laws allowing the free movement of goods between member states, national law only allowed CBD that was extracted from hemp fiber and seeds. The court ruled that this French law was at odds with EU regulations and had a similar effect to restrictions on imports.

With this legalization of the use of CBD in cosmetics within the EU bloc, companies such as Flora Growth Corp. (NASDAQ: FLGC) that have beauty products containing cannabidiol could see major bursts of growth as they enter the European market.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom athttps://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – IBN Announces Collaboration for Upcoming Lift&Co. Expo

IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, today announced that it will serve as media sponsor for the Lift&Co. Expo. Well-known for becoming Canada’s biggest event for cannabis consumers, industry professionals, investors and the media, this year’s Lift&Co. Expo is set to take place at Toronto’s Metro Toronto Convention on Nov. 18-21, 2021. Returning in an in-person format, the event will feature upwards of 250 exhibitors from around the world and bring together Canada’s top business leaders, innovators and regulators to share their perspectives and approaches on the most important issues facing Canada’s cannabis business sector. In its capacity as the event’s media sponsor, IBN will work to further the distribution and publication of content generated for the event.

To view the full press release, visit https://cnw.fm/ZJ683

About IBN

IBN (“InvestorBrandNetwork”) consists of financial brands introduced to the investment public over the course of 15+ years.

With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

CannabisNewsWire (“CNW”) , one of 50+ brands within our InvestorBrandNetwork (“IBN”), is a specialized information service that (1) aggregates cannabis news; (2) provides CannabisNewsBreaks to quickly update investors in the space; (3) enhances corporate press releases; (4) provides social media distribution via IBN to 2+ million likes and followers; and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of 5,000+ key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only).

For more information, please visit https://www.InvestorBrandNetwork.com.

Please see full terms of use and disclaimers on IBN’s website, applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands 2022 R&D Programs to Evaluate Potential Treatment Options for Alzheimer’s and Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its plans for several new and ongoing DehydraTECH(TM)-applied R&D programs for 2022. According to the update, the studies mentioned in the announcement represent only a fraction of Lexaria’s 2022 work programs. “Calendar 2022 will continue to see significant milestones in utilizing DehydraTECH-CBD for investigation of heart disease and hypertension; and separately, for oral nicotine delivery as an alternative to smoking,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “We are delighted to announce that DehydraTECH as an enhanced drug delivery platform will also be evaluated for characteristics and potential treatment options for hormone replacement, dementia, rheumatoid disease and diabetes.” To view the full press release, visit https://cnw.fm/VCto4 About Lexaria Bioscience Corp. Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1-2 hours to minutes and mask unwanted tastes; it is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — New Cannabis Users Show Soft Spot for Beverages, Edibles

America’s cannabis industry has achieved a great deal despite its young age. Initially, smoking cannabis flower was the most common consumption method, but as the industry matured, cannabis companies started developing alternative marijuana products. Customers can now buy a wide variety of cannabis-infused edibles and concentrates, which were a lot safer than flower because they do not involve smoking. However, if the cannabis market has proved one thing, it’s that it is constantly in flux, with customer preferences evolving and companied coming up with new products to meet demand.

These days, edibles and beverages are winning over more new users compared to other consumption methods. This is partly because consumers are turning away from flower and vapes due to the respiratory risks they present, industry observers say. Dominic Cundari, general manager at Michigan-based ArborSide, says that he sees new users, plenty of them with years of smoking cigarettes behind them. who don’t want to put another combustible in their bodies. Consequently, they have been turning toward edibles, which present a significantly reduced health risk. Despite national trends that skew toward concentrates and flower, Cundari says edibles have been outselling concentrates at his store.

Cannabis-infused beverages have also seen a surge in popularity as customers seek alternatives to alcohol. Beverages are relatively new to the market, mostly because the technology needed to brew consistently smooth cannabis drinks still hasn’t been perfected, and experts say the beverage segment is poised to experience significant growth. Edibles are also looking at a lucrative future, Cundari and other industry players believe, partly due to the ease of use, popular brands, familiarity and new innovations. America’s cannabis space doesn’t have many well-known brands because of strict advertising limitations, but Cundari believes branding will play a major role in attracting and retaining customers.

With Michigan’s recreational cannabis market steadily maturing, more cannabis companies are promoting their products. People are becoming accustomed to seeing these advertisements, says Cundari, and this will help promote their brands and make them more recognizable.

Jeff Finnerty, the head of marketing at Ayr Wellness, a multistate operator based in New York, has also noted the increased customer interest in infused beverages and edibles. Innovations such as nano-emulsification, which allow beverage companies to finally infuse cannabinoids into water, as well as familiarity are partly responsible for this shift, he says. He notes that beverages and edibles are especially popular with new users who may be nervous about smoking or vaping and find beverages and edibles more familiar.

Entities such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are at the forefront of pushing the path of innovation in the cannabis drinks space; these companies stand to reap major benefits as these drinks carve out a larger share of the total marijuana market.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Cannabis Retailers Find New Ways to Gain More Consumers

The legal cannabis industry has grown competitive as time has gone by and more companies have ventured into the lucrative space. This has led companies to go the extra mile to get more consumers, by incorporating more features into their retail operations that allow them to stand out.

Figures show that last year, the average retail size space in marijuana stores grew amid increasing consumer demand, with sizes increasing 35% and 50% for recreational shops and medical dispensaries respectively.

David Fettner, a managing partner at Grow America Builders, reveals that in states where the recreational market is more mature and the competition greater, companies looked for different ways to separate themselves from the others. Grow America Builders is a design-build construction company that specializes in the marijuana industry. The company is based in Illinois. Fettner explained that most of the company’s clients sought ways to make their security subtle and designed their shops with VIP rooms, which catered to the needs of consumers with deep pockets.

Over in Michigan, David and Edgar Ramon and Cory Roberts have plans to develop a marijuana grow operation, consumption lounge and retail store. The partners bought four acres of land for their new venture, called Fields Cannabis.

Ramon says that their objective was to establish a destination spot where consumers could have an immersive experience, eat and be entertained. They plan to use AI and virtual reality to give their consumers and visitors an immersive experience by allowing them to tour the site, all without physically visiting the growing facilities.

Other companies that aren’t focused on distinguishing themselves through their physical locations have focused on other aspects of their businesses. For instance, Deep Roots Harvest, a marijuana retailer based in Nevada, is working on boosting its online experience in regards to consumer feedback.

The company allows consumers to place their orders prior to their arrival and pick them up as soon as they get there or have them delivered, which reduces wait time significantly. Deep Roots Harvest also has merchandising areas in its stores where consumers can purchase T-shirts and other items.

Other companies, including Planet 13 Holdings, have expanded their retail space, enhanced their sound systems and installed video walls, which all boost the consumer’s experience. The Las Vegas-based retailer also has magnetic walls in its premises, which make it seem like its products are rotating at different speeds and floating, which affords its consumers a 360-degree experience.

Other companies such as American Cannabis Partners have perfected the science of moving quickly into legal cannabis markets that have just been opened, and this is an ideal strategy because the companies can dominate the market before many players become active there.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Yet Another Study Says Government-Sourced Marijuana Akin to Hemp

Cannabis research has been hampered by federal law for decades. Only one institution, the University of Mississippi, has been allowed by the Drug Enforcement Administration (DEA) to cultivate cannabis for research purposes, and researchers have long said that the plant material provided by the university is subpar and does not measure up to the cannabis sold in dispensaries across the country.

With some studies finding that this cannabis is often contaminated by mold in many cases, industry stakeholders have argued that the DEA needs to approve more cultivators. Now a new study has revealed what most cannabis researchers already suspected: the cannabis grown at the country’s only federally authorized source is genetically akin to hemp.

While hemp and marijuana both belong to the cannabis family, differing THC levels set them apart. THC is the chemical that makes people feel “high,” and it is usually present in large quantities in marijuana. Hemp, on the other hand, contains little to no THC and cannot intoxicate you. Published in the scientific journal “Frontiers,” the new study found that the cannabis grown on the University of Mississippi farm, and the cannabis sold in licensed dispensaries are genetically distinct. The researchers analyzed 49 samples of cultivated hemp and wild hemp as well as a couple of varieties of commercial marijuana and the “research-grade” cannabis cultivated at the University of Mississippi.

The results of the analysis showed that marijuana from the federally licensed facility and most of the drug-type strains sold in legal cannabis markets had a significant genetic difference, the researchers say. The “research-grade” cannabis was so genetically different from state-legal marijuana that it shared genetic similarities with the hemp samples. As such, the researchers say that based on their analyses, it seems that the marijuana that is supplied by National Institute on Drug Abuse for scientific research is genetically different from retail drug-type cannabis strains. It does not align with what consumers are purchasing and consuming, the researchers say, and they hope that the study’s results will push NIDA and the National Institutes of Health (“NIH”) to support the cultivation of the strains most commonly used by the public.

This study aligns with what previous studies into the matter have found; cannabis research needs plenty of reform. Federally licensed grow facilities will not just have to cultivate drug-type cannabis strains, but most of the different cannabis strains that are represented in the market as well. With millions of Americans already using cannabis medically and recreationally, such barriers to proper cannabis research present a significant public health issue.

Once additional manufacturers/growers are licensed, the future research done will stand a chance of giving findings that closely represent the effects of marijuana products made by industry actors such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) rather than those that aren’t reflective of the reality lived by consumers.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Army Recruits with History of Cannabis Use Perform Like Other Soldiers

A new analysis funded by the government has found that past marijuana use has little to no effect on overall performance of army recruits. The analysis found that recruits who had a history of cannabis use were just as likely as their peers to advance in rank. They were also more likely to leave the army due to drug issues but less likely to leave as a result of performance or health issues. The analysis also found no evidence that the legalization trend spreading across the United States had affected recruit outcomes.

The report, which was compiled by the RAND Corporation, states that recruits with a documented history of behavioral health conditions or cannabis as well as waivered recruits were in some cases likely to perform better in comparison to their counterparts.

The report focuses on waivers that permit the U.S. Army to reconsider applicants who had initially been disqualified for a variety of reasons, including the use of marijuana. Applicants with a documented history of marijuana use as well as those who test positive for cannabis need waivers to enlist into the army. This also applies to individuals diagnosed with depression, anxiety disorders or ADHD.

In a blog post, an official from RAND Corp. stated that without the presence of waivers, about one-third of individuals aged 18 or older would be prevented from enlisting because of failed cannabis drug tests. The official noted that recruits who were allowed to join the army despite their history of cannabis use performed like other soldiers.

The Arroyo Center, a federally funded research and development center under RAND Corp, was asked by the U.S. Army to conduct an analysis of the performance of recruits who had received waivers. The analysis gathered records on every recruit who entered the U.S. Army between 2001 and 2012, with the researchers noting that the analysis didn’t find a statistically substantial relationship between the performance of a recruit and a documented history of marijuana use.

Overall, the researchers found that the performance of recruits wouldn’t change significantly if waivers were increased, noting that in some cases, the impact would be improvements in performance. Currently, those wishing to join the army have the option of requesting positive tests for cannabis during their physical exams. Applicants can also request waivers for misdemeanor convictions for driving while impaired or under the influence of cannabis and for the possession of paraphernalia or marijuana.

The authors of the report acknowledge that while some of their findings reinforced existing views, most differed from their expectations.

It looks as if science is gradually dispelling many of the misconceptions that have surrounded marijuana, and a time may come when sector players such as Hero Technologies Inc.(OTC: HENC) will operate in an environment that views cannabis just like any other commodity.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Additional Order as Its Ecosystem Continues to Power Trials, Pilots and Studies in Plant-Based Medicine

RYAH Group (CSE: RYAH) today announced its receipt of an additional order for future shipments of hundreds of its proprietary RYAH Smart Dry Herb Inhalers and accessories to its United Kingdom-based industry partner, an international clinic undertaking one of the world’s largest and most comprehensive clinical trials in plant-based medicine. The order follows the recently announced initial shipment, and the devices will be used by a growing number of participants of the major U.K.-based clinical trial. Over the next five years, the trial is planned to engage tens of thousands of United Kingdom patients and aims to focus on studying the safety and efficacy of plant-based therapies on chronic pain. “The additional order from the U.K. for the RYAH connected devices further expands our product and data footprint as the RYAH ecosystem continues to power trials, pilots and studies in plant-based medicine therapies worldwide,” said Gregory Wagner, CEO of RYAH Group. “We are anticipating our manufacturing operations to begin additional production runs, as we expect the U.K. study to accelerate orders for RYAH Smart Inhalers over the coming months.”

To view the full press release, visit https://cnw.fm/RThma

About RYAH Group Inc.

RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates Health Insurance Portability and Accountability Act (“HIPAA”)-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. With a strong intellectual property portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle. For more information, visit www.RYAHGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://cnw.fm/RYAH

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Sell-Out of First Shipment of Keef Brands

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, sold out of its initial shipment of Keef Brands’ award-winning beverage line. The shipment was sent to the British Columbia Liquor Distribution Branch (“BCLDB”), the sole wholesale distributor of nonmedical cannabis in British Columbia. The product line is the number-one selling cannabis-infused beverage brand in the United States. The BCLDB shipment included two of the brands most popular options: Bubba Kush Root Beer and Orange Kush Classic Soda. The company noted that additional production runs are already underway to meet the strong customer demand. “Keef’s reputation as an award-winning beverage brand has preceded it, and Canadians have been eager to be able to purchase the line here in Canada,” said BevCanna Enterprises president Melise Panetta in the press release. “As the exclusive manufacturer of Keef Brands products in Canada, we’re happy to be able to offer British Columbians this premier brand, and even happier that consumers have responded so positively.”

To view the full press release, visit https://cnw.fm/0H0lJ

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the BevCanna team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a world-class, 40,000-square-foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210 million bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with number-one U.S. cannabis beverage company Keef Brands. For more information about the company, please visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BEV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com